Sepsis is a common condition, and more than 19 million cases of severe sepsis (i.e. cases where organ dysfunction has occurred as a result of sepsis) occur each year Using clinically relevant in vitro models, the authors show that exposing neutrophils to MPLA, in contrast to LPS, does not result in the release of reactive oxygen species and myeloperoxidase. In contrast to LPS, pre-exposure of MPLA treated neutrophils to a blocking antibody for TLR4 augemented myeloperoxidase release, suggesting that LPS and MPLA differentially modulates TLR4. Despite ameliorated production of superoxide and myeloperoxidase, MPLA exposed neutrophils retained P.aeruginosa killing abilities, implying that bacterial killing may not be related to the amount of enzymes released by neutrophils, and intriguingly that superoxide independent killing mechanisms may exist, at least in MPLA exposed neutrophils.
Ruchaud-Sparagano and colleagues also observed no difference in the release of TNFα, IL-1β and IL-10 from MPLA and LPS treated neutrophils. However, there was a significant reduction in the release of the potent neutrophil chemoattractant IL-8 3 from MPLA treated cells, mediated via the PI3kinase pathway. LPS exposure was also found to increase neutrophil cell surface TLR4 expression, a phenomenon that did not occur with MPLA. The contrasting effects of MPLA and LPS are summarized in Table One The observations that administration of MPLA after LPS exposure reduced superoxide and myeloperoxidase release, and that MPLA abrogated increased TLR4 
